# Sparing in Neuromuscular Blockade in COVID 19 ICU

> **NCT04459533** · — · COMPLETED · sponsor: **Hospices Civils de Lyon** · enrollment: 250 (actual)

## Conditions studied

- Neuromuscular Blockade
- Human Characteristics
- Complication of Medical Care
- Intensive Care Unit Acquired Weakness

## Interventions

- **DEVICE:** TOF protocol

## Key facts

- **NCT ID:** NCT04459533
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-01
- **Primary completion:** 2020-06-01
- **Final completion:** 2020-06-01
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2020-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04459533

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04459533, "Sparing in Neuromuscular Blockade in COVID 19 ICU". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04459533. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*